Free Trial

Anpario's (ANP) "House Stock" Rating Reaffirmed at Shore Capital

Anpario logo with Consumer Defensive background

Key Points

  • Investment analysts at Shore Capital have reaffirmed their "house stock" rating for Anpario (LON:ANP).
  • Anpario has a market capitalization of £83.14 million and a significant P/E ratio of 2,009.01.
  • The company engages in producing natural feed additives for animal health, hygiene, and nutrition, with several product brands in its portfolio.
  • Five stocks we like better than Anpario.

Anpario (LON:ANP - Get Free Report)'s stock had its "house stock" rating reissued by Shore Capital in a research note issued on Wednesday, Marketbeat reports.

Anpario Stock Performance

Shares of LON:ANP traded down GBX 0.66 during midday trading on Wednesday, reaching GBX 492. The company had a trading volume of 28,287 shares, compared to its average volume of 40,838. The company's 50 day moving average price is GBX 408.39 and its 200 day moving average price is GBX 413.44. The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.10. The stock has a market cap of £83.37 million, a P/E ratio of 2,014.74 and a beta of 0.58. Anpario has a 52-week low of GBX 286 and a 52-week high of GBX 510.

Anpario (LON:ANP - Get Free Report) last issued its quarterly earnings results on Wednesday, September 10th. The company reported GBX 16.87 earnings per share for the quarter. Anpario had a net margin of 9.23% and a return on equity of 8.74%. As a group, sell-side analysts anticipate that Anpario will post 23.5757801 EPS for the current fiscal year.

About Anpario

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

See Also

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.